image
Cyclacel Pharmaceuticals, Inc. CYCC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.374
-4.91 %
$ 2.35 M
Market Cap
-0.02
P/E
BALANCE SHEET
8.8 M ASSETS
-67.98%
Growth Rates
1Year -67.98%
3Years -37.92%
5Years -14.98%
7Years -10.84%
10Years -13.02%
8.2 M LIABILITIES
-31.64%
Growth Rates
1Year -31.64%
3Years 32.27%
5Years 12.49%
7Years 6.18%
10Years 0.90%
607 K EQUITY
-96.09%
Growth Rates
1Year -96.09%
3Years -73.67%
5Years -47.54%
7Years -36.31%
10Years -31.83%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Cyclacel Pharmaceuticals, Inc.
image
Current Assets 7.44 M
Cash & Short-Term Investments 3.38 M
Receivables 0
Other Current Assets 4.07 M
Non-Current Assets 1.36 M
Long-Term Investments 0
PP&E 102 K
Other Non-Current Assets 1.26 M
Current Liabilities 8.16 M
Accounts Payable 3.54 M
Short-Term Debt 0
Other Current Liabilities 4.62 M
Non-Current Liabilities 37 K
Long-Term Debt 37 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
ASSETS
Cash & Cash Equivalents 3.4 18.3 36.6 33.4 11.9 17.5 23.9 16.5 20.4 24.2 31.1 16.4 24.4 29.5 11.5 24.2 31.0 44.2 13.6 13.9 2.2 0 0 0
Short Term Investments 0 0 0 0 0 0 0.1 0.1 0.1 0.1 0.1 0.2 0 0 0 1.5 27.8 9.8 6.9 33.4 11.3 0 0 0
Receivables 0 0 0 1.3 1.3 0 0 2.1 3.0 3.5 2.3 0 0 0 0 0 2.5 2.5 0 0 0 0 0 0
Inventory 0 (5.6) 0.6 0.7 0.7 0.6 0.5 1.0 1.0 1.1 3.0 0 0.2 0.2 0.1 0.5 0.2 1.4 0 0 0 0 0 0
Other Current Assets 4.1 7.0 4.4 0.8 0.8 2.3 1.9 1.0 1.1 1.4 1.7 2.5 1.2 1.4 1.7 2.8 2.3 4.1 3.2 1.0 0.5 0 0 0
Total Current Assets 7.4 24.4 40.9 35.5 14.0 19.8 26.0 19.6 24.6 29.0 35.2 18.9 25.8 31.1 13.4 29.0 63.8 58.2 20.9 48.3 14.1 0 0 0
PP&E 0.1 0.2 94 K 1.3 1.3 36 K 29 K 45 K 0.2 0.4 0.3 0.1 0.2 0.4 0.9 1.7 3.0 2.1 0.2 6.2 2.8 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.6 2.7 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.3 2.9 1.6 (1.3) (1.3) 0 0 0 0 0 72 K 0.4 0 0 0.2 0.2 0.2 0.2 0.3 1.1 1.7 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21.5 24.7 28.5
Total Assets 8.8 27.5 42.6 36.8 15.3 19.8 26.0 19.7 24.8 29.4 35.5 19.4 26.0 31.5 14.5 31.0 75.9 63.3 21.4 55.6 18.5 21.5 24.7 28.5
LIABILITIES
Accounts Payable 3.5 2.6 2.1 0.5 0.9 2.7 1.6 2.5 1.9 2.8 2.5 2.3 1.7 1.7 1.7 0.8 5.0 2.2 2.2 1.7 1.0 0 0 0
Short Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 89 K 0.3 1.6 12.5 0 0 0
Other Current Liabilities 4.6 5.0 3.2 2.0 1.5 1.7 2.6 2.8 3.8 4.7 5.0 7.1 4.8 4.8 8.1 7.9 9.8 5.7 2.8 4.1 1.3 0 0 0
Total Current Liabilities 8.2 7.4 5.3 2.5 2.4 4.5 4.1 5.3 5.8 7.5 7.5 9.3 6.5 6.5 9.8 8.6 14.7 7.9 5.2 7.4 14.7 0 0 0
Long Term Debt 37 K 0.1 30 K 1.1 1.2 0 0 0 0 0 0 0 0 0 0 0.6 0 0 78 K 2.7 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.8) 0 0 0 0
Other Liabilities 0 0 0 0 0 100 K 0.1 0.1 0.2 0.2 0 0 0 0 0 1.1 3.2 1.4 1.5 0.6 68.6 0 0 0
Total Liabilities 8.2 12.0 5.3 3.5 3.6 4.6 4.2 5.4 5.9 7.7 7.5 9.3 6.5 6.5 9.8 10.3 17.9 9.4 6.8 11.5 83.3 69.7 61.0 53.9
EQUITY
Common Stock 1 K 4.5 10 K 6 K 17 K 12 K 12 K 4 K 35 K 23 K 19 K 9 K 54 K 47 K 26 K 20 K 20 K 16 K 19 K 19 K 2 K 0 0 0
Retained Earnings (428.3) (406.2) (385.0) (366.1) (357.6) (349.8) (342.5) (335.0) (323.2) (308.8) (289.4) (270.2) (257.1) (241.8) (222.3) (202.7) (162.3) (138.3) (155.6) (126.2) (86.6) (68.1) (48.7) (29.2)
Other Accumulative Comprehensive Income/Loss (0.9) (1.3) (0.7) (0.7) (0.8) (0.8) (0.8) (0.7) (0.6) (0.5) (0.1) 48 K 57 K 31 K 20 K 42 K (2.6) (2.5) (0.2) (1.4) (2.8) 0 0 0
Total Equity 0.6 15.5 37.3 33.3 11.7 15.3 21.8 14.3 18.8 21.7 28.0 10.0 19.5 24.9 4.6 20.6 58.0 53.9 14.6 44.1 (64.8) (48.1) (36.3) (25.4)
Total Liabilities and Equity 8.8 27.5 42.6 36.8 15.3 19.8 26.0 19.7 24.8 29.4 35.5 19.4 26.0 31.5 14.5 31.0 75.9 63.3 21.4 55.6 18.5 21.5 24.7 28.5
SHARES OUTSTANDING
Common Shares Outstanding 0.9 0.7 0.6 0.2 54.4 K 0.6 0.4 0.2 0.1 91.5 K 63.2 K 29.9 K 29.9 K 22.5 K 13.2 K 12.2 K 11.8 K 7.97 K 3.96 K 7.4 K 8.79 K 3.96 K 3.96 K 3.96 K